A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib
Clinical trial NCT04366713 · COMPLETED
Trial details
- NCT number
- NCT04366713
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-12-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.